Protein Design
Reprogramming the Rules: How AI Is Transforming De Novo Protein Design in Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-08Apr 15, 2025
Spintronics
Spintronics and the Future of Drug Design
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-03Apr 04, 2025
Structural Biology
The Disruptive Impact of Structural Biology on Biopharmaceutical Innovation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-13Mar 02, 2025
Option Agreement
Merck KGaA, Darmstadt, Germany, Enters Into Option Agreement With Quris on Its BioAI Platform for Clinical Safety Prediction
Quris
PR-M02-22-08Feb 09, 2022
Drug Design
Janssen, Iktos Collaborate on In Silico Drug Design
Emilie Branch
Pharma's Almanac
PAO-M05-19-NI-022May 21, 2019
Drug Design
Computer-Aided Drug Design Leads to Real Candidate and New Biotech Startup
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M01-19-NI-024Jan 30, 2019